The Leicester Royal Infirmary is a National Health Service hospital in Leicester, England. It is located to the south-west of the city centre. It has an accident and emergency department and is managed by of the University Hospitals of Leicester NHS Trust.

There are 890 beds in Leicester Royal Infirmary.

During the past decade, Leicester Royal Infirmary conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 40 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 32 clinical trials were completed. i.e. 78% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leicester Royal Infirmary" #1 sponsor was "Children's Cancer and Leukaemia Group" with 29 trials, followed by "University College, London" with 15 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "University of Birmingham" with 8 trials sponsored and "Cancer Research UK" with 8 trials sponsored. Other sponsors include 163 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leicester Royal Infirmary" #1 collaborator was "Cancer Research UK" with 20 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator and "Celgene" with 4 trials as a collaborator. Other collaborators include 184 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "Leicester Royal Infirmary" are "Brain and Central Nervous System Tumors" (15 trials), "Lymphoma" (13 trials), "Multiple Myeloma" (9 trials), "Neuroblastoma" (8 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "Leicester Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Leicester Royal Infirmary" are "Drug" (174 trials), "Procedure" (50 trials), "Biological" (46 trials), "Other" (39 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (26 trials), "carboplatin" (22 trials), "Placebo" (20 trials), "cisplatin" (20 trials) and "cyclophosphamide" (19 trials). Other intervention names were less common.

The vast majority of trials in "Leicester Royal Infirmary" are 214 trials for "All" genders, 13 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 54 active trials in "Leicester Royal Infirmary". 1 are not yet recruiting, 36 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 108 completed trials in Leicester Royal Infirmary, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Leicester Royal Infirmary, 26 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 28 trials that are defined as “Not Applicable".